Dr. Rajagopal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
275 Collier Rd NW
Ste 300
Atlanta, GA 30309Phone+1 404-605-2800Fax+1 404-351-5983
Education & Training
- Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2005 - 2007
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2001 - 2002
- University of WashingtonResidency, Internal Medicine, 1999 - 2001
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Transitional Year, 1998 - 1999
- University of Michigan Medical SchoolClass of 1998
Certifications & Licensure
- CA State Medical License 2001 - Present
- GA State Medical License 2007 - 2026
- OH State Medical License 2002 - 2007
- HI State Medical License 2002 - 2002
- WA State Medical License 1999 - 2001
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Atlanta Magazine: Top Doctors Castle Connolly, 2011-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
- Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsBeyond Static Planning: Computational Predictive Modeling to Avoid Coronary Artery Occlusion in TAVR.Kimberly Holst, Taylor Becker, J Trent Magruder, Pradeep Yadav, James Stewart
The Annals of Thoracic Surgery. 2025-01-01 - 3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.Firas Zahr, Basel Ramlawi, Michael J Reardon, G Michael Deeb, Steven J Yakubov
JACC. Cardiovascular Interventions. 2024-07-22 - Changes in Left Ventricular Function and Outcomes After Trancatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation.Stamatios Lerakis, Annapoorna S Kini, Gennaro Giustino, Malcolm Anastasius, Federico M Asch
Journal of the Society for Cardiovascular Angiography & Interventions. 2024-05-01
Journal Articles
- Transcatheter Mitral-Valve Repair in Patients with Heart FailureJoAnn Lindenfeld, Saibal Kar, Michael J Mack, Samir R Kapadia, Gregg W Stone, Ian J Sarembock, William T Abraham, Andreas Brieke, David J Cohen, Steven O Marx, Brian W..., The New England Journal of Medicine
Authored Content
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- Early Experience with New Transcatheter Mitral Valve ReplacementJanuary 2018
- Early Experience with New Transcatheter Mitral Valve ReplacementJanuary 2018
- Early Experience with New Transcatheter Mitral Valve ReplacementJanuary 2018
- Join now to see all
Press Mentions
- Piedmont Completes 1st Mitral Valve Replacement with Novel Technique in USSeptember 30th, 2021
- Piedmont Performs Its First Procedure as Part of CLASP IID Trial Involving Transcatheter Mitral Valve Repair SystemSeptember 22nd, 2020
- Venus Medtech and Opus Medical Therapies, LLC Announce Partnership for Transcatheter Mitral Valve Replacement (TMVR) and Transcatheter Tricuspid Valve Replacement (TTVR) in Greater China MarketMay 2nd, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: